New additional markers in ALMS1 gene
Thirteen new additional markers in ALMS1 gene are available for the detection of Alström Syndrome.
Sequencing of the ABCA4 gene
Asper Biotech is now offering sequence analysis of the entire coding region of the ABCA4 gene.
New test – Leber Hereditary Optic Neuropathy
New addition to the Asper Ophthalmics portfolio: Leber Hereditary Optic Neuropathy, testing three primary mutations in mtDNA.
Asper Biotech at ICHG
Asper Biotech will be attending at the 12th International Congress of Human Genetics in Canada. We are glad to meet you in our exhibition booth (#311) on 11-14th of October at the Le Palais des Congrès in Montreal.
Updated version of Sensorineural Hearing Loss test
Asper Biotech has updated Sensorineural Hearing Loss (SNHL) genetic test. The new version includes five additional genes – KCNQ4, TCM1, MYO15A, MYO7A, as well as 232kb deletion from GJB6 gene [del(GJB6-D13S1854)]. Now the SNHL microarray covers the analysis of 11 genes – GJB2, GJB6, GJB3, SLC26A5, SLC26A4, MTNR1, MTTS1, KCNQ4, TCM1, MYO15A, MYO7A – and detects 246 mutations instead of 198 of the earlier version.
European Human Genetics Conference 2011
Visit Asper Biotech’s booth (#280) at the European Human Genetics Conference on 28-31th of May 2011 in Amsterdam, The Netherlands. Our company, represented by CEO Eneli Oitmaa and Medical Geneticist Dr Kairit Joost, is also involved in a Poster Session. The posters will be presented respectively on the topics “Diagnostic testing for Male Factor Infertility using APEX microarrays” and “Microchip for determination of the syndromes tied to increased Nuchal Translucency”.
Sequencing of the RPE65 gene
Asper Biotech is now offering sequence analysis of the entire coding region of the RPE65 gene.
Updated version of Congenital Stationary Night Blindness genetic test is now available
Asper Biotech, in collaboration with scientific partners, has updated Congenital Stationary Night Blindness (CSNB) genetic test. The new version includes two additional genes – GRK1 and TRPM1, associated with Congenital Stationary Night Blindness. Now the CSNB microarray covers the analysis of 11 genes – RHO, PDE6B, GNAT1, CABP4, GRM6, SAG, NYX, CACNA1F, CACNA2D, GRK1, TRPM1 – and detects 159 mutations instead of 126 of the earlier version.
Asper Biotech’s collaboration with Polish leading genetic testing center
Asper Biotech is presenting its collaboration with our to-be exclusive partner for Asper’s eye diseases testing in Poland Centrum Genetyki Medycznej and jointly participating at the Congress of the Polish Society of Ophthalmology in Warsaw on 10th-13th of June. This is a great opportunity to spread the word about Asper’s tests to the 1500 eye doctors from all around Poland. Asper is proud to collaborate with Centrum GENESIS and the renowned Professors Prof. Anna Latos-Bielenska and Prof. Maciej Krawczynski, who is also delivering a series of lectures on genetic eye diseases and the benefits of Asper’s tests in everyday diagnostics work. A many-fold increase in sample number from Poland is set as a common goal for Asper’s and Centrum’s collaboration in 2010.
16th Retina International World Congress
Asper Biotech will be represented at the 16th Retina International World Congress in Stresa, Italy. You are welcome to visit our booth on 26-27 June 2010.
|
